The IGF-I/IGF-I Receptor Pathway: Implications in the Pathophysiology of Thyroid Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|12|24|2881-2891

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.12, Iss.24, 2005-11, pp. : 2881-2891

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The IGF-I Signaling Pathway

By  

Current Pharmaceutical Design, Vol. 13, Iss. 7, 2007-03 ,pp. : 663-669

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial [Hot Topic: Targeting the IGF-I Receptor Signaling Pathway:Implications for Human Cancer Therapy (Executive Editors: A. Ciampolillo and F. Giorgino) ]

By  

Current Pharmaceutical Design, Vol. 13, Iss. 7, 2007-03 ,pp. : 661-662

Bentham Science Publishers

Access to resources Recommend Favorite

The IGF-I Axis in Thyroid Carcinoma

By  

Current Pharmaceutical Design, Vol. 13, Iss. 7, 2007-03 ,pp. : 729-735

Bentham Science Publishers

Access to resources Recommend Favorite

IGF-I Abuse in Sport

By  

Current Drug Abuse Reviews, Vol. 2, Iss. 3, 2009-09 ,pp. : 263-272

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Insulin Receptor Isoforms and Hybrid Insulin/IGF-I Receptors in Human Cancer

By  

Current Pharmaceutical Design, Vol. 13, Iss. 7, 2007-03 ,pp. : 671-686

Bentham Science Publishers

Access to resources Recommend Favorite